Department of Population Health, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK.
Brighton and Sussex University Hospitals Trust, Brighton, BN2 5BE, UK.
Trans R Soc Trop Med Hyg. 2021 Nov 1;115(11):1317-1329. doi: 10.1093/trstmh/trab137.
Malnutrition is a leading cause of morbidity and mortality in children aged <5 y, especially in low- and middle-income countries (LMICs). Unlike severe acute malnutrition, moderate acute malnutrition (MAM) affects greater numbers globally, and guidelines lack a robust evidence base. This systematic review and meta-analysis assessed the evidence for lipid-based nutrient supplements (LNSs), fortified blended flours (FBFs) and nutrition counselling, in the treatment of MAM.
Four databases were systematically searched for studies conducted in LMICs that compared the effectiveness of food-based products with any comparator group in promoting recovery from MAM in children aged 6-59 mo. Where appropriate, pooled estimates of effect were estimated using random-effects meta-analyses.
A total of 13 trials were identified for inclusion. All used active controls. There was evidence of increased probability of recovery (gaining normal weight-for-height and/or mid-upper arm circumference) among children treated with LNSs compared with children treated with FBFs (risk ratio 1.05, 95% CI 1.01 to 1.09, p=0·009).
Based on a relatively small number of studies mainly from Africa, LNSs are superior to FBFs in improving anthropometric recovery from MAM. Current evidence for the use of food supplements in MAM treatment is based on comparisons with active controls. Future studies should assess a wider range of comparator groups, such as nutrition education/counselling alone, and outcomes, including body composition, morbidity and development.
营养不良是 5 岁以下儿童发病率和死亡率的主要原因,尤其是在中低收入国家。与严重急性营养不良不同,中度急性营养不良(MAM)在全球范围内影响更大,但指南缺乏强有力的证据基础。本系统评价和荟萃分析评估了脂基营养素补充剂(LNS)、强化混合粉(FBF)和营养咨询在治疗 MAM 中的证据。
系统检索了四个数据库中在中低收入国家开展的研究,这些研究比较了食品类产品与任何对照组在促进 6-59 月龄儿童从中度急性营养不良中恢复的有效性。在适当的情况下,使用随机效应荟萃分析来估计合并效应的估计值。
共确定了 13 项符合纳入标准的试验。所有试验均使用了活性对照。与接受 FBF 治疗的儿童相比,接受 LNS 治疗的儿童体重恢复正常(身高体重比和/或中上臂围增加)的可能性更高(风险比 1.05,95%CI 1.01-1.09,p=0·009)。
基于来自非洲的相对较少数量的研究,LNS 在改善 MAM 的人体测量学恢复方面优于 FBF。目前关于在 MAM 治疗中使用食品补充剂的证据是基于与活性对照的比较。未来的研究应评估更广泛的对照组,例如单独的营养教育/咨询,以及包括身体成分、发病率和发育在内的结果。